ArticleFrontiers in pharmacology2025

Safety, tolerability, pharmacokinetics, immunogenicity and pharmacodynamics of 9MW1911, an anti-ST2 monoclonal antibody: results from a first-in-human phase 1 study.

Qian Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.